Cite
Development of High Affinity Camptothecin-Bombesin Conjugates That Have Targeted Cytotoxicity for Bombesin Receptor-containing Tumor Cells.
MLA
Moody, Terry W., et al. “Development of High Affinity Camptothecin-Bombesin Conjugates That Have Targeted Cytotoxicity for Bombesin Receptor-Containing Tumor Cells.” Journal of Biological Chemistry, vol. 279, no. 22, May 2004, pp. 23580–89. EBSCOhost, https://doi.org/10.1074/jbc.M401938200.
APA
Moody, T. W., Mantey, S. A., Pradhan, T. K., Schumann, M., Nakagawa, T., Martinez, A., Fuselier, J., Coy, D. H., & Jensen, R. T. (2004). Development of High Affinity Camptothecin-Bombesin Conjugates That Have Targeted Cytotoxicity for Bombesin Receptor-containing Tumor Cells. Journal of Biological Chemistry, 279(22), 23580–23589. https://doi.org/10.1074/jbc.M401938200
Chicago
Moody, Terry W., Samuel A. Mantey, Tapas K. Pradhan, Michael Schumann, Tomoo Nakagawa, Alfredo Martinez, Joseph Fuselier, David H. Coy, and Robert T. Jensen. 2004. “Development of High Affinity Camptothecin-Bombesin Conjugates That Have Targeted Cytotoxicity for Bombesin Receptor-Containing Tumor Cells.” Journal of Biological Chemistry 279 (22): 23580–89. doi:10.1074/jbc.M401938200.